サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1544024

ポリメラーゼ連鎖反応の世界市場

Polymerase Chain Reaction
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=142.54円
ポリメラーゼ連鎖反応の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ポリメラーゼ連鎖反応の世界市場は2030年までに131億米ドルに達する見込み

2023年に93億米ドルと推定されるポリメラーゼ連鎖反応の世界市場は、2023年から2030年にかけてCAGR 5.0%で成長し、2030年には131億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPCR機器は、CAGR 4.9%を記録し、分析期間終了時には34億米ドルに達すると予測されます。PCR試薬＆消耗品セグメントの成長率は、分析期間中CAGR 5.0％と推定されます。

米国市場は25億米ドルと推定・予測、中国はCAGR7.6%で成長予測

米国のポリメラーゼ連鎖反応市場は2023年に25億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と4.4%と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界のポリメラーゼ連鎖反応市場- 主要動向と促進要因まとめ

ポリメラーゼ連鎖反応：現代分子生物学の礎石

ポリメラーゼ連鎖反応（PCR）は、特定のDNA配列を増幅することができる分子生物学の革命的な技術です。1983年にKary Mullisによって開発されたPCRは、研究者が比較的短時間で特定のDNA断片を数百万コピー作ることを可能にしました。このプロセスでは、加熱と冷却のサイクルが繰り返され、DNA二重らせんの変性、標的配列へのプライマーのアニーリング、DNAポリメラーゼ酵素によるこれらのプライマーの伸長が促進されます。通常、反応混合物にはDNA鋳型、2種類のプライマー、遊離ヌクレオチド、緩衝液、変性に必要な高温に耐えるTaqポリメラーゼなどの耐熱性DNAポリメラーゼが含まれます。この周期的プロセスにより、標的DNA領域が指数関数的に増幅され、PCRは遺伝子研究、診断、法医学において不可欠なツールとなります。

PCRは様々な分野でどのように利用されているか？

PCRは、迅速かつ正確にDNAを増幅する能力により、様々な科学・医療分野で広く利用されています。医療診断では、PCRは細菌やウイルスのような病原体を検出し定量するために採用され、HIV、肝炎、COVID-19のような感染症の同定を可能にします。遺伝学的検査もPCRの恩恵を受けており、遺伝性疾患に関連する変異を同定し、早期診断と個別化治療計画を容易にすることができます。法医学の分野では、PCRは犯罪現場からの微細なDNAサンプルの分析に極めて重要であり、容疑者と犯罪行為を結びつける証拠を提供します。さらに、PCRはバイオテクノロジーや製薬産業における研究開発においても重要な役割を果たしており、クローニング、遺伝子発現解析、遺伝子組み換え生物の作製などに用いられています。PCRの多用途性と正確さは、遺伝学の理解を進め、公衆衛生と安全を向上させるために不可欠な技術となっています。

PCR技術と応用の現在の動向は？

PCRの技術と応用は、分子生物学の進歩と迅速で正確な遺伝子解析に対する需要の高まりに後押しされ、絶えず進化しています。重要な動向の1つは、リアルタイムPCRとしても知られる定量的PCR（qPCR）の開発であり、これはDNAまたはRNAをリアルタイムで定量することを可能にし、遺伝子発現やウイルス量に関する貴重な洞察を提供します。デジタルPCR（dPCR）はもう一つの技術革新であり、サンプルを何千もの個々の反応に分割することでより高い精度と感度を提供し、核酸の絶対定量を可能にします。マイクロフルイディクスの進歩により、ポータブルPCR装置が開発され、資源が限られた環境や現場での遺伝子検査が可能になっています。さらに、1回の反応で複数の標的を増幅できるマルチプレックスPCRは、時間と試薬の消費を減らすことで遺伝子検査の効率を高めています。これらの動向は、PCRの精度、効率、アクセシビリティを向上させるための継続的な努力を反映しており、多様な分野での応用の可能性を広げています。

PCR市場の成長を促進する要因は？

PCR市場の成長は、高度な遺伝子解析と診断ツールに対する需要の増加を反映するいくつかの要因によって牽引されています。ヘルスケア分野の拡大、特に感染症の流行と早期診断の必要性の高まりは、PCR技術の重要な促進要因です。qPCRやdPCRの開発のような技術の進歩は、PCRの能力と精度を高め、様々なアプリケーションでの採用を促しています。個別化医療への注目の高まりと、治療決定の指針となる正確な遺伝子検査の必要性も、市場成長を後押ししています。さらに、バイオテクノロジーと製薬業界における研究開発活動の増加は、創薬と遺伝子工学におけるPCRの需要を後押ししています。法医学や環境モニタリングにおけるPCRの使用の増加はさらに市場拡大を支えています。PCR技術の革新と改良のための継続的な研究開発努力は、PCR市場の力強い成長を保証し、分子生物学の進歩と公衆衛生の成果の改善におけるPCRの重要な役割を強調しています。

調査対象企業の例（全17件）

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP14084

Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030

The global market for Polymerase Chain Reaction estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the PCR Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.6% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized

Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.

How Is PCR Utilized Across Different Fields?

PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.

What Are the Current Trends in PCR Technology and Applications?

The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.

What Factors Are Driving the Growth in the PCR Market?

The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.

Select Competitors (Total 17 Featured) -

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Polymerase Chain Reaction - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Molecular Diagnostics Propels Market Growth
    • Advances in PCR Technologies and Techniques Drives Adoption
    • Increasing Use in Infectious Disease Detection Expands Market Opportunities
    • Growth in Genetic and Genomic Research Strengthens Business Case for PCR
    • Development of Real-Time and Digital PCR Spurs Market Expansion
    • Expansion of Oncology and Cancer Research Generates Demand
    • Increasing Focus on Personalized Medicine Accelerates Market Growth
    • Enhanced Sensitivity and Specificity of Modern PCR Sustains Market Demand
    • Rising Investments in Biotechnology Research and Development Expands Addressable Market
    • Technological Innovations in PCR Reagents and Consumables Strengthens Market Position
    • Growth in Forensic and Clinical Applications Propels Market Growth
    • Increasing Demand for PCR in Agricultural and Food Testing Sustains Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Clinical Diagnostic Labs & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharmaceutical & Biotechnology Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Polymerase Chain Reaction Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION